Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effects of SGLT2 Inhibitors on Erythropoiesis in Heart Failure
Sponsor: University Medical Centre Ljubljana
Summary
This retrospective cohort study investigates the effects of SGLT2 inhibitor therapy on erythropoiesis and its association with cardiac and renal outcomes in patients with chronic heart failure. The study will compare hematological parameters, echocardiographic measures, and clinical outcomes between patients who initiated SGLT2 inhibitor therapy and a matched control group receiving guideline-directed medical therapy alone over a 12-month follow-up period.
Official title: Effects of SGLT2 Inhibitors on Erythropoiesis and Associated Cardio-Renal Outcomes in Heart Failure Patients: A Retrospective Cohort Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
85
Start Date
2019-01-01
Completion Date
2026-12-31
Last Updated
2026-03-17
Healthy Volunteers
No
Conditions
Locations (1)
University Medical Centre Ljubljana
Ljubljana, Slovenia